News Cello Health acquires Firstlight PR's health team Cello Health has boosted its comms offering with the acquisition of Firstlight Public Relations' ten-strong healthcare business.
News Keenova eyes Xiaflex as first drug for plantar fibromatosis Keenova is hoping that its Xiaflex drug can become the first approved therapy for plantar fibromatosis, a debilitating condition affecting the feet.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
